Eli Lilly

Biotech By Matthew Herper

FDA approves Lilly diabetes drug that analysts expect to be a big seller

Exclusive By Nicholas Florko

Senate FDA legislation will include dietary supplement, cosmetic reforms

First Opinion By Michelle Collins and Cherie Burke

The case of RaDonda Vaught highlights a double standard for nurses and physicians

First Opinion By Ge Bai and Brian Blase

Turn off the spigot for hospitals’ Covid-19 relief funding

Business By Bob Herman

Real estate firms own nearly 1 in 10 health care properties

Pharmalot By Ed Silverman

Up and down the ladder: The latest comings and goings

Pharmalot By Ed Silverman

Pharmalittle: Aspen may close South Africa Covid vaccine plant due to lack of orders; Roche insists it can overcome latest setback

First Opinion By Billy Kenber

The man behind ‘value-based pricing’ saw pharma distorting his message — and walked away